Socioeconomic, racial, and institutional factors significantly affect treatment access and patient outcomes in Guillain-Barré syndrome, despite standardized care guidelines in the US.
Yagiz M. Altun, MD, PhD
Advertisement
Articles by Yagiz M. Altun, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Panel Backs 6 Peptides for Compounding
2
Teclistamab-Talquetamab Combo Cuts Myeloma Progression Risk by 89%
3
FAQs: Cyclospora Recovery, Treatment, and Outbreak Prevention Strategies
4
Study Shows Potential for Low-Dose CAR T, With Implications for Increased Access
5